Milan, Italy

Aldo Bertelli

This inventor holds 6 USPTO granted patents and 1 EPO patent. Top assignees: Rorer Italiana S.p.a., Seuref A.g.. Active years: 1976-1980.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aldo Bertelli. Retrieved from https://idiyas.com/inventor/aldo-bertelli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 1.0

ph-index = 3

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 1976-1980

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Aldo Bertelli: Innovator in Therapeutic Compounds

Introduction

Aldo Bertelli is a notable inventor based in Milan, Italy. He has made significant contributions to the field of therapeutic compounds, holding a total of 6 patents. His work focuses on innovative chemical compounds that have various medical applications.

Latest Patents

Bertelli's latest patents include advancements in benzoic acid derivatives and therapeutic compositions. One of his inventions relates to compounds with the general formula where R1 is a hydrogen atom or a lower alkyl radical, and n is an integer from 1 to 4. These compounds exhibit choleretic, antiatherosclerotic, hypocholesterolemic, and antiphlogistic activities. Another significant patent involves p-aminomethyl-benzene-sulfonamide derivatives, which have antibacterial properties and promote healing and protection for skin burns.

Career Highlights

Throughout his career, Aldo Bertelli has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Rorer Italiana S.p.A. and Seuref A.G. His experience in these organizations has contributed to his expertise in developing therapeutic compounds.

Collaborations

(Section skipped due to space constraints.)

Conclusion

Aldo Bertelli's innovative work in the field of therapeutic compounds showcases his dedication to advancing medical science. His patents reflect a commitment to improving health outcomes through chemical innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…